UAS Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04M Buy
+4,200
New +$4.29M 1.09% 11
2026
Q1
Sell
-2,700
Closed -$2.9M 14
2025
Q4
$2.9M Buy
+2,700
New +$2.58M 0.61% 11
2024
Q4
Sell
-4,840
Closed -$4.29M 16
2024
Q3
$4.29M Sell
4,840
-7,236
-60% -$6.51M 1.04% 9
2024
Q2
$10.9M Buy
12,076
+4,466
+59% +$3.57M 2.62% 9
2024
Q1
$5.92M Buy
7,610
+3,410
+81% +$2.43M 1.58% 8
2023
Q4
$2.45M Buy
+4,200
New +$2.45M 0.62% 12

Other funds holding LLY

UAS Asset Management's LLY Position: Q2 2026 in Review

UAS Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 4,200 shares worth $5.04M. The stake represents 1.09% of the portfolio and ranks #11 among its holdings. This is a return to the name: UAS Asset Management previously reported a position in LLY as recently as Q4 2025.

UAS Asset Management first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. The position peaked at $10.9M in Q2 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • UAS Asset Management held 4,200 shares of Eli Lilly worth $5.04M as of Q2 2026.
  • Eli Lilly was a new UAS Asset Management position in Q2 2026.
  • Eli Lilly made up 1.09% of UAS Asset Management's portfolio in Q2 2026, its #11 holding.
  • UAS Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • UAS Asset Management's Eli Lilly position peaked at $10.9M in Q2 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on UAS Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.